257 related articles for article (PubMed ID: 35628501)
1. Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
D'Amato M; Iadarola P; Viglio S
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628501
[TBL] [Abstract][Full Text] [Related]
2. Sputum proteomics in inflammatory and suppurative respiratory diseases.
Gray RD; MacGregor G; Noble D; Imrie M; Dewar M; Boyd AC; Innes JA; Porteous DJ; Greening AP
Am J Respir Crit Care Med; 2008 Sep; 178(5):444-52. PubMed ID: 18565957
[TBL] [Abstract][Full Text] [Related]
3. Spit it out! How could the sputum proteome aid clinical research into pulmonary diseases?
Iadarola P; Viglio S
Expert Rev Proteomics; 2017 May; 14(5):391-393. PubMed ID: 28388247
[No Abstract] [Full Text] [Related]
4. Induced sputum: a window to lung pathology.
Nicholas B; Djukanović R
Biochem Soc Trans; 2009 Aug; 37(Pt 4):868-72. PubMed ID: 19614609
[TBL] [Abstract][Full Text] [Related]
5. Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome.
Burg D; Schofield JPR; Brandsma J; Staykova D; Folisi C; Bansal A; Nicholas B; Xian Y; Rowe A; Corfield J; Wilson S; Ward J; Lutter R; Fleming L; Shaw DE; Bakke PS; Caruso M; Dahlen SE; Fowler SJ; Hashimoto S; Horváth I; Howarth P; Krug N; Montuschi P; Sanak M; Sandström T; Singer F; Sun K; Pandis I; Auffray C; Sousa AR; Adcock IM; Chung KF; Sterk PJ; Djukanović R; Skipp PJ; The U-Biopred Study Group
J Proteome Res; 2018 Jun; 17(6):2072-2091. PubMed ID: 29737851
[TBL] [Abstract][Full Text] [Related]
6. diaPASEF Proteomics and Feature Selection for the Description of Sputum Proteome Profiles in a Cohort of Different Subtypes of Lung Cancer Patients and Controls.
Arenas-De Larriva MDS; Fernández-Vega A; Jurado-Gamez B; Ortea I
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955870
[TBL] [Abstract][Full Text] [Related]
7. Shotgun proteomic analysis of human-induced sputum.
Nicholas B; Skipp P; Mould R; Rennard S; Davies DE; O'Connor CD; Djukanović R
Proteomics; 2006 Aug; 6(15):4390-401. PubMed ID: 16819730
[TBL] [Abstract][Full Text] [Related]
8. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease.
Ohlmeier S; Vuolanto M; Toljamo T; Vuopala K; Salmenkivi K; Myllärniemi M; Kinnula VL
J Proteome Res; 2008 Dec; 7(12):5125-32. PubMed ID: 19367700
[TBL] [Abstract][Full Text] [Related]
9. Advances in proteomic techniques for biomarker discovery in COPD.
Casado B; Luisetti M; Iadarola P
Expert Rev Clin Immunol; 2011 Jan; 7(1):111-23. PubMed ID: 21162654
[TBL] [Abstract][Full Text] [Related]
10. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
Terracciano R; Preianò M; Palladino GP; Carpagnano GE; Barbaro MP; Pelaia G; Savino R; Maselli R
Proteomics; 2011 Aug; 11(16):3402-14. PubMed ID: 21751363
[TBL] [Abstract][Full Text] [Related]
11. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects.
Sloane AJ; Lindner RA; Prasad SS; Sebastian LT; Pedersen SK; Robinson M; Bye PT; Nielson DW; Harry JL
Am J Respir Crit Care Med; 2005 Dec; 172(11):1416-26. PubMed ID: 16166615
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases.
Pastor L; Vera E; Marin JM; Sanz-Rubio D
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33430153
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the sputum proteome and transcriptome in smokers and early-stage COPD subjects.
Titz B; Sewer A; Schneider T; Elamin A; Martin F; Dijon S; Luettich K; Guedj E; Vuillaume G; Ivanov NV; Peck MJ; Chaudhary NI; Hoeng J; Peitsch MC
J Proteomics; 2015 Oct; 128():306-20. PubMed ID: 26306861
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma.
Rollet-Cohen V; Bourderioux M; Lipecka J; Chhuon C; Jung VA; Mesbahi M; Nguyen-Khoa T; Guérin-Pfyffer S; Schmitt A; Edelman A; Sermet-Gaudelus I; Guerrera IC
J Proteomics; 2018 Aug; 185():1-7. PubMed ID: 30032860
[TBL] [Abstract][Full Text] [Related]
16. Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state.
Cagnone M; Salvini R; Bardoni A; Fumagalli M; Iadarola P; Viglio S
Electrophoresis; 2019 Jan; 40(1):151-164. PubMed ID: 30216498
[TBL] [Abstract][Full Text] [Related]
17. Identification of ENO1 as a potential sputum biomarker for early-stage lung cancer by shotgun proteomics.
Yu L; Shen J; Mannoor K; Guarnera M; Jiang F
Clin Lung Cancer; 2014 Sep; 15(5):372-378.e1. PubMed ID: 24984566
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of sputum reveals novel biomarkers for various presentations of asthma.
Cao C; Li W; Hua W; Yan F; Zhang H; Huang H; Ying Y; Li N; Lan F; Wang S; Chen X; Li J; Liu J; Lai T; Bao Z; Cao Y; Zhao Y; Huang G; Huang L; Huang Y; Wu P; Peng C; Chen Z; Chung KF; Zhong N; Ying S; Shen H
J Transl Med; 2017 Aug; 15(1):171. PubMed ID: 28778200
[TBL] [Abstract][Full Text] [Related]
19. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD.
Ohlmeier S; Mazur W; Linja-Aho A; Louhelainen N; Rönty M; Toljamo T; Bergmann U; Kinnula VL
J Proteome Res; 2012 Feb; 11(2):599-608. PubMed ID: 22053820
[TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
